Rose J W, Lorberboum-Galski H, Fitzgerald D, McCarron R, Hill K E, Townsend J J, Pastan I
Neurovirology Research Laboratory VAMC, Salt Lake City, UT 84148.
J Neuroimmunol. 1991 Jun;32(3):209-17. doi: 10.1016/0165-5728(91)90190-i.
IL2-PE40 is a chimeric protein composed of human interleukin-2 (IL2) genetically fused to a modified form of Pseudomonas exotoxin lacking the cell recognition domain. IL2-PE40 is cytotoxic for IL2 receptor-bearing lymphocytes in culture and can inhibit activation of T cells in vivo. IL2-PE40 can significantly diminish antigen-stimulated proliferation of lymphocytes sensitized to myelin basic protein. Intraperitoneal administration of IL2-PE40 not only markedly inhibits the clinical manifestations of adoptively transferred relapsing experimental allergic encephalomyelitis but also dramatically reduces both inflammation and demyelination characteristic of the disease.
IL2-PE40是一种嵌合蛋白,由与人白细胞介素-2(IL2)基因融合的改良型绿脓杆菌外毒素组成,该外毒素缺乏细胞识别结构域。IL2-PE40在培养物中对携带IL2受体的淋巴细胞具有细胞毒性,并且在体内可抑制T细胞的激活。IL2-PE40可显著减少对髓鞘碱性蛋白致敏的淋巴细胞的抗原刺激增殖。腹腔注射IL2-PE40不仅可显著抑制过继转移的复发性实验性变应性脑脊髓炎的临床表现,还可显著减轻该疾病特有的炎症和脱髓鞘。